相似文献
1
Pulmonary arterial hypertension registries: past, present and into the future.
Eur Respir Rev. 2019 Dec 18;28(154). doi: 10.1183/16000617.0128-2019. Print 2019 Dec 31.
2
Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective.
Am J Respir Crit Care Med. 2021 Mar 15;203(6):675-677. doi: 10.1164/rccm.202012-4350ED.
3
Call it by the correct name-pulmonary hypertension not pulmonary arterial hypertension: growing recognition of the global health impact for a well-recognized condition and the role of the Pulmonary Vascular Research Institute.
Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L992-L994. doi: 10.1152/ajplung.00098.2020. Epub 2020 Apr 1.
4
Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations.
Eur Respir Rev. 2019 Dec 18;28(154). doi: 10.1183/16000617.0050-2019. Print 2019 Dec 31.
5
Genotypes and Phenotypes of Chinese Pediatric Patients With Idiopathic and Heritable Pulmonary Arterial Hypertension-A Single-Center Study.
Can J Cardiol. 2019 Dec;35(12):1851-1856. doi: 10.1016/j.cjca.2019.07.628. Epub 2019 Aug 1.
6
The Clinical Value of Proposed Risk Stratification Tools in Pediatric Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2019 Nov 15;200(10):1312-1315. doi: 10.1164/rccm.201902-0266LE.
7
Where's the Easy Button? The Many Barriers to Care for Patients With Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2022 Nov 15;11(22):e027967. doi: 10.1161/JAHA.122.027967. Epub 2022 Nov 12.
8
[Genetic diagnostics and molecular approaches in pulmonary arterial hypertension].
Pneumologie. 2023 Nov;77(11):862-870. doi: 10.1055/a-2145-4663. Epub 2023 Nov 14.
9
Pediatric pulmonary hypertension: diagnosis and management.
Curr Opin Cardiol. 2016 Jan;31(1):78-87. doi: 10.1097/HCO.0000000000000243.
10
Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertension.
J Heart Lung Transplant. 2022 Jul;41(7):861-865. doi: 10.1016/j.healun.2022.03.024. Epub 2022 Apr 7.
引用本文的文献
1
Demographic, hemodynamic characteristics, and therapeutic trends of pulmonary hypertension patients: The Pulmonary Hypertension Mexican registry (REMEHIP).
Pulm Circ. 2024 Jun 17;14(2):e12395. doi: 10.1002/pul2.12395. eCollection 2024 Apr.
2
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group.
Pulm Circ. 2023 Dec 21;13(4):e12317. doi: 10.1002/pul2.12317. eCollection 2023 Oct.
3
Critical Care Management of Decompensated Right Heart Failure in Pulmonary Arterial Hypertension Patients - An Ongoing Approach.
J Crit Care Med (Targu Mures). 2021 Aug 5;7(3):170-183. doi: 10.2478/jccm-2021-0020. eCollection 2021 Jul.
4
Reply to Jin and to Sun .
Am J Respir Crit Care Med. 2021 Dec 15;204(12):1494-1495. doi: 10.1164/rccm.202107-1725LE.
5
Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL).
Ther Adv Chronic Dis. 2021 Mar 25;12:20406223211002961. doi: 10.1177/20406223211002961. eCollection 2021.
6
Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL).
J Clin Med. 2020 Jan 8;9(1):173. doi: 10.3390/jcm9010173.
本文引用的文献
1
Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations.
Eur Respir Rev. 2019 Dec 18;28(154). doi: 10.1183/16000617.0050-2019. Print 2019 Dec 31.
2
Risk stratification and medical therapy of pulmonary arterial hypertension.
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01889-2018. Print 2019 Jan.
3
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension.
Eur Respir J. 2018 Oct 18;52(4). doi: 10.1183/13993003.00678-2018. Print 2018 Oct.
4
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
Eur Respir J. 2017 Aug 3;50(2). doi: 10.1183/13993003.00889-2017. Print 2017 Aug.
5
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
Eur Respir J. 2017 Aug 3;50(2). doi: 10.1183/13993003.00740-2017. Print 2017 Aug.
6
A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.
Eur Heart J. 2018 Dec 14;39(47):4175-4181. doi: 10.1093/eurheartj/ehx257.
7
Rare respiratory diseases are ready for primetime: from Rare Disease Day to the European Reference Networks.
Eur Respir J. 2017 Feb 23;49(2). doi: 10.1183/13993003.00085-2017. Print 2017 Feb.
8
Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study.
Eur Respir J. 2014 Jun;43(6):1691-7. doi: 10.1183/09031936.00116313. Epub 2014 Mar 13.
9
The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.
Chest. 2012 Feb;141(2):354-362. doi: 10.1378/chest.11-0676. Epub 2011 Jun 16.
Zotero 插件